Search
for
Sort by
Research 961–990 of 1000+
- Exploring novel management options for alopecia areata
- 53607 Common Contact Allergens Implicated in Frontal Fibrosing Alopecia Found in Over-the-Counter Hair Growth Serums and Solutions
- Skin of color repigmentation after phenol-croton oil chemical peel
- Medical and procedural treatment of androgenetic alopecia – Where are we?
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- Mucocutaneous reactions to chemotherapy
- Primary cicatricial alopecias: clinicopathology of 112 cases
- Medical treatments for male and female pattern hair loss
- Evaluation and treatment of male and female pattern hair loss
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia
- 308-nm excimer laser therapy in alopecia areata
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Follicular mucinosis: A detailed morphologic and immunopathologic study
- Treatment of pediatric alopecia areata: A systematic review
- Anabolic effects of testosterone are preserved during inhibition of 5α-reductase
- Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo
- Sarcoidosis: Are there differences in your skin of color patients?
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Tufted hair folliculitis developing in a recalcitrant lesion of pemphigus vulgaris
- Systematic review of the therapeutic roles of adipose tissue in dermatology
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Cutaneous immunopathology of androgenetic alopecia
- Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis
- Intrinsic factors in the pathogenesis of hidradenitis suppurativa: Genetics, hormones, and the microbiome
- Follicular dystrophy of immunosuppression
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Ensuring safety in cytotoxic drug preparation: A systematic review of guidelines addressing education for pharmacy professionals
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials